Low a ketogenic diet with standard chemotherapeutic and radiotherapeutic options may help improve tumor response, although more cancer is needed. One randomized trial in humans- designed to examine cardiovascular endpoints — revealed an diet in lung cancer and a doubling of cancer-related deaths in men randomized to a high vegetable rizk diet. Carb Reports Inthe… Read More »
Cancer-fighting foods include apples, berries, and fatty fish. A registered dietitian can help you make a plan. For the other cancer sites examined there was no significant heterogeneity between the 3 dietary groups, but the RRs for the following 3 cancers were significantly lower in fish eaters than in meat eaters: colon cancer RR: 0.… Read More »
Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to ‘kinder’ treatments for children with bone cancer, and save lives. Current treatment is gruelling, with outdated chemotherapy cocktails and limb amputation. But despite all of this, the five-year survival rate is poor at just 42 per… Read More »
Read the Full Article for Free! Read the Full Article for Free! You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access Unlock censored health information that Google doesn’t want you to read… Read More »
Bristol Myers Squibb’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease. The company revealed Thursday that its PD-1 fighter, against placebo, had lengthened the time muscle-invasive urothelial carcinoma patients could remain disease-free after surgery. All patients saw benefit,… Read More »
Winship Cancer Institute of Emory University (Winship) and Emory investigators are testing whether an anticancer drug can reduce lung inflammation in hospitalized COVID-19 patients, possibly preventing the need for intubation and lowering mortality. The drug is called duvelisib, and it was FDA-approved in 2018 for the treatment of relapsed or refractory chronic lymphocytic leukemia or… Read More »